217 related articles for article (PubMed ID: 22295114)
1. Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
van der Horst PH; Wang Y; Vandenput I; Kühne LC; Ewing PC; van Ijcken WF; van der Zee M; Amant F; Burger CW; Blok LJ
PLoS One; 2012; 7(1):e30840. PubMed ID: 22295114
[TBL] [Abstract][Full Text] [Related]
2. Fluorene-9-bisphenol inhibits epithelial-mesenchymal transition of human endometrial cancer Ishikawa cells by repressing TGF-β signaling pathway.
Wang L; Zhuang T; Li F; Wei W
Environ Sci Pollut Res Int; 2019 Sep; 26(26):27407-27413. PubMed ID: 31327139
[TBL] [Abstract][Full Text] [Related]
3. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer.
Yoriki K; Mori T; Kokabu T; Matsushima H; Umemura S; Tarumi Y; Kitawaki J
Sci Rep; 2019 Apr; 9(1):6697. PubMed ID: 31040369
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice.
Hanekamp EE; Kühne LM; Grootegoed JA; Burger CW; Blok LJ
Endocr Relat Cancer; 2004 Dec; 11(4):831-41. PubMed ID: 15613456
[TBL] [Abstract][Full Text] [Related]
6. Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer.
Hanekamp EE; Gielen SC; Smid-Koopman E; Kühne LC; de Ruiter PE; Chadha-Ajwani S; Brinkmann AO; Grootegoed JA; Burger CW; Huikeshoven FJ; Blok LJ
Clin Cancer Res; 2003 Sep; 9(11):4190-9. PubMed ID: 14519645
[TBL] [Abstract][Full Text] [Related]
7. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
[TBL] [Abstract][Full Text] [Related]
8. Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer.
Wang Y; Hanifi-Moghaddam P; Hanekamp EE; Kloosterboer HJ; Franken P; Veldscholte J; van Doorn HC; Ewing PC; Kim JJ; Grootegoed JA; Burger CW; Fodde R; Blok LJ
Clin Cancer Res; 2009 Sep; 15(18):5784-93. PubMed ID: 19737954
[TBL] [Abstract][Full Text] [Related]
9. Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
Wang T; Wang M; Fang S; Wang Q; Fang R; Chen J
Oncotarget; 2017 Mar; 8(12):18991-19012. PubMed ID: 28177909
[TBL] [Abstract][Full Text] [Related]
10. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract][Full Text] [Related]
11. Role of steroid receptor-associated and regulated protein in tumor progression and progesterone receptor signaling in endometrial cancer.
Liu J; Wang Z; Zhou J; Wang J; He X; Wang J
Chin Med J (Engl); 2023 Nov; 136(21):2576-2586. PubMed ID: 37144734
[TBL] [Abstract][Full Text] [Related]
12. [Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
Lu Y; Liao QP; Chen CL; Yu L
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):475-9. PubMed ID: 17068617
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rh2 induces apoptosis and inhibits epithelial-mesenchymal transition in HEC1A and Ishikawa endometrial cancer cells.
Kim JH; Kim M; Yun SM; Lee S; No JH; Suh DH; Kim K; Kim YB
Biomed Pharmacother; 2017 Dec; 96():871-876. PubMed ID: 29078265
[TBL] [Abstract][Full Text] [Related]
14. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.
Smid-Koopman E; Blok LJ; Kühne LC; Burger CW; Helmerhorst TJ; Brinkmann AO; Huikeshoven FJ
J Soc Gynecol Investig; 2003 Jan; 10(1):49-57. PubMed ID: 12517594
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B.
Chi S; Liu Y; Zhou X; Feng D; Xiao X; Li W; Zhao Y; Wang H
Cancer Chemother Pharmacol; 2019 Feb; 83(2):277-287. PubMed ID: 30443761
[TBL] [Abstract][Full Text] [Related]
16. Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and/or PRB-expressing endometrial cancer cell lines.
Smid-Koopman E; Kuhne LC; Hanekamp EE; Gielen SC; De Ruiter PE; Grootegoed JA; Helmerhorst TJ; Burger CW; Brinkmann AO; Huikeshoven FJ; Blok LJ
J Soc Gynecol Investig; 2005 May; 12(4):285-92. PubMed ID: 15866122
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-Mediated Gene Knockout of ARID1A Promotes Primary Progesterone Resistance by Downregulating Progesterone Receptor B in Endometrial Cancer Cells.
Wang H; Tang Z; Li T; Liu M; Li Y; Xing B
Oncol Res; 2019 Sep; 27(9):1051-1060. PubMed ID: 31072420
[TBL] [Abstract][Full Text] [Related]
18. MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-β-Treated Endometrial Stromal Cells via the MAPK and Wnt/β-Catenin Signaling Pathways.
Wang L; Liu D; Wei J; Yuan L; Zhao S; Huang Y; Ma J; Yang Z
Pathol Oncol Res; 2021; 27():1609761. PubMed ID: 34257616
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel mechanism of NF-kappaB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2.
Davies S; Dai D; Feldman I; Pickett G; Leslie KK
Gynecol Oncol; 2004 Aug; 94(2):463-70. PubMed ID: 15297189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
